Invention Grant
US08314123B2 5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof
有权
5,6或7-取代的-3-（杂）芳基异喹啉胺衍生物及其治疗用途
- Patent Title: 5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof
- Patent Title (中): 5,6或7-取代的-3-（杂）芳基异喹啉胺衍生物及其治疗用途
-
Application No.: US13268678Application Date: 2011-10-07
-
Publication No.: US08314123B2Publication Date: 2012-11-20
- Inventor: Young Bok Lee , Chang Ho Ahn , Won-Jea Cho
- Applicant: Young Bok Lee , Chang Ho Ahn , Won-Jea Cho
- Applicant Address: US MD Rockville
- Assignee: Rexahn Pharmaceuticals, Inc.
- Current Assignee: Rexahn Pharmaceuticals, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Venable LLP
- Agent Keith G. Haddaway; Lars H. Genieser
- Main IPC: A61K31/472
- IPC: A61K31/472 ; C07D217/22
Abstract:
The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.
Public/Granted literature
- US20120029012A1 5, 6, or 7-SUBSTITUTED -3-(HETERO) ARYLISOQUINOLINAMINE DERIVATIVES AND THERAPEUTIC USE THEREOF Public/Granted day:2012-02-02
Information query
IPC分类:
